AI found a thermostable mRNA vaccine formula in one month that survives 37°C for two months

Key Findings

🔇 Side effects and immunity can be separated — at least in mice

• A study identified a conserved inflammatory burst peaking around six hours after dosing that governs reactogenicity across mRNA-lipid nanoparticles, adenoviral vectors, and AAV9 — and showed it's driven by nucleic acid sensing, not the lipid shell.
• Suppressing that early signal reduced side effects across multiple mouse models while preserving antibody responses, T-cell immunity, and gene-editing outcomes, and reduced liver toxicity and platelet drops associated with lipid nanoparticle dosing.

💉 Novavax's protein vaccine causes meaningfully fewer side effects than Pfizer's mRNA shot

• In a randomized, double-blinded trial of 901 participants who had already received at least two mRNA doses, 62% of the Novavax group reported systemic symptoms on day one versus 76% for Pfizer-BioNTech — a difference of nearly 14 percentage points.
• Local reactions followed the same pattern: 81% vs. 93%. Most events were mild, and by day six, more than 80% of both groups reported no systemic symptoms at all.

🧬 A common mRNA modification causes translation errors — but there's a simple fix

• N1-methylpseudouridine, the modification used in approved COVID mRNA vaccines to reduce immune activation, increases a specific type of ribosomal frameshifting on UUUC sequence motifs, generating unintended peptides.
• Swapping those slippery motifs for UUCC or UUUU sequences eliminated the frameshifting effect in cell-based reporters, a fully reconstituted translation system, and single-molecule imaging — suggesting codon optimization can close the gap.

🧫 A viral protein borrowed from an insect virus dramatically boosts self-amplifying RNA output

• Expressing the B2 protein from Nodamura virus alongside self-amplifying RNA increased transgene expression by preventing the RNA-sensing machinery from shutting down protein production — without suppressing interferon signaling or the vaccine's immune-stimulating properties.
• The mechanism differed by cell type: in stem cells, B2 blocked small RNA accumulation; in somatic cells, it prevented a kinase from halting translation.

🔬 Bigger lipid nanoparticles for bigger genetic cargo — a size-aware design strategy

• Screening a library of 384 ionizable lipids using a large 5.7-kilobase mRNA identified a lead lipid, LC-1, that maintained a structured, fusion-ready internal geometry as cargo size increased — unlike two widely used benchmark lipids that became disordered.
• After intravenous delivery in mice, LC-1 achieved up to 79% gene knockout in liver and 48% in brain, outperforming benchmarks by up to fourfold across three delivery routes.

🫀 mRNA delivered to the liver can coax it into a regenerative state after injury

• Researchers delivered a four-factor reprogramming cocktail via liver-targeted lipid nanoparticles in mice, generating two distinct populations of liver progenitor-like cells without requiring prior injury or triggering a strong inflammatory response.
• Treating mice with this mRNA system before acetaminophen-induced liver damage was associated with enhanced regeneration, suggesting transient reprogramming may prime the liver for repair.